Electronic cigarettes (e-cigarettes) are increasingly used, but their health effects remain unclear. The primary ingredients of e-cigarette liquid, propylene glycol and flavoring chemicals (eg, diacetyl or diketone), are respiratory irritants and harmful to the lungs.
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Methods | During 2012-2013, we surveyed secondary 1 (US grade 7, typically aged 12 years) to secondary 6 students from 75 randomly selected schools using an anonymous questionnaire based on the Global Youth Tobacco Survey. 4 An invitation letter was sent to parents, and student participation was voluntary. Ethics approval was granted by the institutional review board of the University of Hong Kong/Hospital Authority West Cluster. Parental passive oral consent was obtained. A total of 45 128 students (94.5% of all invited) were available for analysis after data cleaning. Smoking status was defined as neversmoking, experimental smoking (smoked once or a few times), ex-smoking (smoked in the past but not now), and current smoking (smoked on ≥1 day in the past 30 days). Use of e-cigarettes in the past 30 days (yes or no), respiratory symptoms (cough or phlegm) for 3 consecutive months in the past 12 months (yes or no), sociodemographic characteristics (sex, age, and perceived family affluence), and secondhand smoke exposure were recorded. We weighted descriptive data by sex, age, and grade distribution of the corresponding general population. Adjusted odds ratios (AORs) of respiratory symptoms due to e-cigarette use were calculated using logistic regression (Stata version 13.0; StataCorp) for all students and by smoking status, adjusting for sociodemographic characteristics, secondhand tobacco smoke exposure, school clustering effects, and, where appropriate, smoking status.
Results | The mean (SD) age was 14.6 (1.9) years, and 51.1% were boys. Only 1.1% (95% CI, 1.0-1.2) of all students, 0.1% (0.1-0.2) of never-smokers, 5.8% (5.2-6.3) of ever-smokers, 2.0% (1.6-2.5) of experimenters, 9.6% (8.3-11.1) of ex-smokers, and 9.6% (8.2-11.2) of current smokers had used e-cigarettes in the past 30 days. Respiratory symptoms were reported by 18.8% of all students, 17.7% of never-smokers, 25.8% of ever-smokers, 21.7% of experimenters, 27.2% of ex-smokers, and 34.3% of current smokers. The Figure shows a higher prevalence of respiratory symptoms in e-cigarette users regardless of smoking status. Overall, e-cigarette use was significantly associated with respiratory symptoms (AOR, 1.28; 95% CI, 1.06-1.56) (Table) . The corresponding AORs (95% CIs) were 2.06 (1.24-3.42) in never-smokers, 1.39 (1.14-1.70) in ever-smokers, and 1.40 (1.02-1.91) in ex-smokers. Positive but nonsignificant associations were observed in experimenters (AOR, 1.09; 95% CI, 0.66-1.80) and current smokers (AOR, 1.15; 95% CI, 0.81-1.62).
Discussion | To our knowledge, we present the first evidence of an association between e-cigarette use and respiratory symptoms in never-and ever-smoking adolescents, which is consistent with findings from other laboratory and adult studies on short-term adverse respiratory functions. 3 Similar ORs between crude and adjusted models suggested the association was unlikely due to confounding effects, and e-cigarette use may independently predict respiratory symptoms. Respiratory symptoms are a simple and useful outcome to demonstrate the short-term health effects of e-cigarette use while P < .001 for all students, P < .01 for never-smokers, P = .01 for ever-smokers, P = .69 for experimenters, P = .04 for ex-smokers, and P = .40 for current smokers. 
